Acasti Pharma Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of prescription drugs for the treatment of cardiovascular diseases. Its lead product candidate is CaPre, an omega-3 phospholipid therapeutic that is in Phase III clinical trial to treat patients with hypertriglyceridemia. The company was incorporated in 2002 and is headquartered in Laval, Canada.
Acasti Pharma Inc CVE:ACST
Today's live share price, quote history, chart & news
About Acasti Pharma Inc
|Name||Acasti Pharma Inc|
|Exchange||TSX Venture Exchange|
|Full time employees||28|